Microbiotix, Inc. is a Massachusetts-based biopharmaceutical company dedicated to the discovery and development of innovative treatments for infectious diseases. Our goal is to develop innovative anti-infective drugs with enhanced delivery modes, favorable resistance profiles, fewer side effects and greater efficacy. We use advanced research methods in medicinal chemistry and biological screening, as well as an extensive library of small molecules to discover unique anti-infective drug candidates. Recognized experts in anti-infective biology and chemistry lead the Microbiotix drug discovery team. Microbiotix expertise is complemented by collaborations with industrial pharmaceutical companies and academic centers.